Differentiated thyroid cancer in a Swedish county long-term results and quality of life

Acta Oncologica

Volumn 49, Issue 4, 2010, Pages 454-459

  Malterling, Rebecka R ^a   Andersson, Roland E ^a   Falkmer, Sture ^a   Falkmer, Ursula ^a   Niléhn, Eva ^a   Jrhult, Johannes ^a  

^a RYHOV COUNTY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DIFFERENTIATED THYROID CANCER; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPOPARATHYROIDISM; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; MALE; METASTASIS; NERVE PARALYSIS; OUTCOME ASSESSMENT; PAPILLARY CARCINOMA; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RECURRENT LARYNGEAL NERVE; SHORT FORM 36; SUBTOTAL THYROIDECTOMY; SURVIVAL RATE; THYROID CANCER; THYROIDECTOMY;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CARCINOMA, PAPILLARY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; REGISTRIES; SAMPLE SIZE; SWEDEN; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77951236873     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841860903544600     Document Type: Article

References (22)

1. Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer incidence in five continents, Volumes I to VIII. Lyon: IARC CancerBase No. 7; 2005.
2. Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447-1463
3. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N Engl J Med 1998;338:297-306.
4. De Groot LJ, Kaplan EL, McCormick M, Straus FH. Natural history, treatment and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:414-424
5. Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 2007;246:375-384
6. Pujol P, Daures JP, Nsakala N, Baldet L, Bringer J, Jaffiol C. Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 1996;81:4318-4323
7. Haigh PI, Urbach DR, Rotstein LE. Extent of thyroidectomy is not a major determinant of survival in low- or highrisk papillary thyroid cancer. Ann Surg Oncol 2005; 12:81-89
8. Lundgren CI, Hall P, Dickman PW, Zedenius J. Influence of surgical and postoperative treatment on survival in differentiated thyroid cancer. Br J Surg 2007;94:571-577
9. Sullivan M, Karlsson J, Ware J. The Swedish SF-36 Health Survey I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 1995;41:1349-1358
10. Persson L-O, Karlsson J, Bengtsson C, Steen B, Sullivan M. The Swedish SF-36 Health Survey II. Evaluation of clinical validity; results from population studies of elderly and women in Gothenburg. J Clin Epidemiol 1998;51:1095-1103 (Pubitemid 28527165)
11. Sullivan M, Karlsson J. The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity; results from normative population. J Clin Epidemiol 1998;51:1005-1113
12. Svensson E. Construction of a single global scale for multi-item assessments of the same variable. Stat Med 2001;20: 3831-3846
13. Lundgren CI, Hall P, Dickman PW, Zedenius J. Clinically significant prognostic factors for differentiated thyroid carcinoma: A population-based, nested case-control study. Cancer 2006;106:524-531
14. Hay ID, McDougall R, Sisson JC. The case against radioiodine remnant ablation in patients with well differentiated thyroid carcinoma. J Nucl Med 2008;49:1395-1397
15. Khanna CM, Dubey YS, Shankar R, Kaur G. Effects of longterm thyroid hormone suppressive treatment of the cardiac functions. Indian Heart J 1997;49:289-292
16. Mercuro G, Panzuto MG, Bina A, Leo M, Cabula R, Petrini L, et al. Cardiac function, physical exercise capacity, and quality of life during long-term thyrotropin-suppressive therapy with levothyroxine: Effect of individual dose tailoring. J Clin Endocrinol Metabol 2000;85:159-164
17. Botella-Carretero JI, Gomez-Bueno M, Barrios V, Caballero C, Garcia-Robles R, Sancho J, et al. Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma. Endocr Relat Cancer 2004; 11:345-356
18. Eroglu A, Berberoglu U, Buruk F, Yildirim E. Completion thyroidectomy for differentiated thyroid carcinoma. J Surg Oncol 1995;59:261-267
19. Pacini F, Elisei R, Capezzone M, Miccoli P, Molinaro E, Basolo F, et al. Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low-and high-risk patients. Thyroid 2001;11:877-881
20. Grigsby PW, Reddy RM, Moley JF, Hall BL. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment. Surgery 2006;140:1043-1049
21. Hoftijzer HC, et al. Quality of life in cured patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 2008;93:200-203
22. Tan LG, Nan L, Thumboo J, Sundram F, Tan LK. Healthrelated quality of life in thyroid cancer survivors. Laryngoscope 2007;117:507-510